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1. INTRODUCTION {#mbo3979-sec-0001}
===============

Since its inception more than 30 years ago, the baculovirus expression system (BES) has been widely employed for recombinant protein expression at massive levels (van Oers, Pijlman, & Vlak, [2015](#mbo3979-bib-0037){ref-type="ref"}; Smith, Summers, & Fraser, [1983](#mbo3979-bib-0034){ref-type="ref"}). Depending on posttranslational modifications in insect cells and larvae, the BES is markedly suitable for eukaryotic protein expression (Kidd & Emery, [1993](#mbo3979-bib-0016){ref-type="ref"}). In recent years, multigene expression employing the BES has been reported (Berger, Fitzgerald, & Richmond, [2004](#mbo3979-bib-0003){ref-type="ref"}; Kanai, Athmaram, Stewart, & Roy, [2013](#mbo3979-bib-0013){ref-type="ref"}; Yao et al., [2012](#mbo3979-bib-0039){ref-type="ref"}). Multigene expression in a single recombinant baculovirus has advantages in expression applications. The expression of double‐chain antibodies and packaging of recombinant adeno‐associated virus (rAAV) are a few examples of this expression system (Furuta, Ogawa, Katsuda, Fujii, & Yamaji, [2010](#mbo3979-bib-0007){ref-type="ref"}; Negrete, Yang, Mendez, Levy, & Kotin, [2007](#mbo3979-bib-0025){ref-type="ref"}).

*Bombyx mori* nucleopolyhedrovirus (*Bm*NPV) is one of the most widely employed baculoviruses for gene expression. In the last 3 decades, *Bm*NPV has undergone modifications in many ways to generate recombinant *Bm*NPV that is more convenient and enhances the expression efficiency of foreign genes (Kato, Kajikawa, Maenaka, & Park, [2010](#mbo3979-bib-0014){ref-type="ref"}; Maeda et al., [1985](#mbo3979-bib-0021){ref-type="ref"}). Compared with the *Ac*MNPV‐cell expression system, the *Bm*NPV‐silkworm system possesses better posttranslational processing and greater expression efficiency (Dojima et al., [2009](#mbo3979-bib-0006){ref-type="ref"}; Usami et al., [2011](#mbo3979-bib-0036){ref-type="ref"}). Previously, we successfully constructed a reBmBac system for recombinant *Bm*NPV with increased efficiency (Liu et al., [2016](#mbo3979-bib-0019){ref-type="ref"}). By utilizing this system, researchers can proficiently and rapidly obtain recombinant baculoviruses and target proteins in silkworms.

Interferons (IFNs) were first discovered in the 1950s, and since then, they have been researched deeply in many fields. Interferons are categorized into three major classes. Type I IFNs are generated by almost any type of cell in response to invading pathogens (Alsharifi, Mullbacher, & Regner, [2008](#mbo3979-bib-0001){ref-type="ref"}). They can induce the expression of specific antiviral proteins and related physiological responses by binding with specific receptors on the cell membrane (Levy, Marie, & Durbin, [2011](#mbo3979-bib-0018){ref-type="ref"}). Type II IFNs possess strong immune regulation ability and can regulate the activity of lymphocytes (Muller et al., [1994](#mbo3979-bib-0024){ref-type="ref"}; Platanias, [2005](#mbo3979-bib-0029){ref-type="ref"}). Type III IFNs have been recently discovered. They have functions similar to those of type I IFNs (Kotenko, [2011](#mbo3979-bib-0017){ref-type="ref"}; Sheppard et al., [2003](#mbo3979-bib-0033){ref-type="ref"}). Some studies indicate that type I and II IFNs demonstrate synergy in the establishment of an antiviral state (Muller et al., [1994](#mbo3979-bib-0024){ref-type="ref"}; Platanias, [2005](#mbo3979-bib-0029){ref-type="ref"}; Sekellick, Lowenthal, O\'Neil, & Marcus, [1998](#mbo3979-bib-0031){ref-type="ref"}).

Chicken IFN‐α (chIFN‐α) is a type I IFN. Research has revealed its antiviral potential against Rous sarcoma virus, Newcastle disease virus, infectious bursal disease virus, and avian influenza virus in vitro and in vivo (Jiang, Yang, & Kapczynski, [2011](#mbo3979-bib-0012){ref-type="ref"}; Marcus, van der Heide, & Sekellick, [1999](#mbo3979-bib-0022){ref-type="ref"}; Meng et al., [2011](#mbo3979-bib-0023){ref-type="ref"}; O\'Neill, Livant, & Ewald, [2010](#mbo3979-bib-0026){ref-type="ref"}). Chicken IFN‐γ (chIFN‐γ) is a type II IFN. It demonstrates avian virus inhibition both in vitro and in vivo and has the capability to prevent poultry coccidiosis (Cardenas‐Garcia et al., [2016](#mbo3979-bib-0004){ref-type="ref"}; Khatri & Sharma, [2008](#mbo3979-bib-0015){ref-type="ref"}; Shah et al., [2010](#mbo3979-bib-0032){ref-type="ref"}). Studies also illustrate that chIFN‐γ enhances the growth performance of reared broilers (Lowenthal, [2001](#mbo3979-bib-0020){ref-type="ref"}). These two IFNs have an immune synergism effect. The combination of chIFN‐α and chIFN‐γ can significantly enhance viral inhibition and elicit an antiviral state (Plachy et al., [1999](#mbo3979-bib-0028){ref-type="ref"}; Sekellick et al., [1998](#mbo3979-bib-0031){ref-type="ref"}).

In the current study, recombinant *Bm*NPV simultaneously carrying the *chIFN‐α* and *chIFN‐γ* genes at distinct gene sites was constructed using the reBmBac system. This recombinant baculovirus was employed for the coexpression of two types of IFN and can provide a foundation for the combination of IFNs and their possible future therapeutic application.

2. MATERIALS AND METHODS {#mbo3979-sec-0002}
========================

A *Bombyx mori*‐derived cell line, Bm5, was cultured in TC100 insect cell culture medium (Applichem) with 10% fetal bovine serum (FBS, Gibco, USA) at 27°C according to published procedures (Summers & Smith, [1987](#mbo3979-bib-0035){ref-type="ref"}). DMEM (Dulbecco\'s modified Eagle\'s medium) and Trypsin‐EDTA were obtained from Thermo Fisher Scientific. Specific pathogen‐free (SPF) fertilized eggs (8--10 days) were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd. The recombinant vesicular stomatitis virus VSV‐GFP was acquired from Lanzhou Veterinary Research Institute, CAAS.

*Escherichia coli* BW25113/pKD46 was obtained from the Molecular, Cellular and Developmental Biology Department, Kline Biology Tower 830, Yale University. The reBmBac vector was constructed in our laboratory. The pVL1393 transfer vector and Lipofectin were acquired from Invitrogen. Rabbit anti‐chicken IFN‐α and IFN‐γ antibodies were obtained from RayBiotech. HRP‐conjugated goat anti‐rabbit IgG was obtained from Abcam.

2.1. Construction of the gene‐targeting vector {#mbo3979-sec-0003}
----------------------------------------------

The **pP10** vector (GenBank ID: MN702625) was used to transfer the target gene into the baculovirus at the *p10* gene site. Homologous targeting arms 232 bp upstream and 118 bp downstream of the *p10* gene were amplified and inserted into the pMD18‐simple vector.

The **pP10‐rpsL‐neo** vector (GenBank ID: MN702626) was utilized to knock out the *p10* gene. The counterselection cassette *rpsL‐neo* (GenBank ID: GU084141.1) was synthesized and inserted into the pP10 vector.

The **pVL1393‐Cα** and **pVL1393‐Cγ** vectors were employed to individually transfer the chicken *interferon‐α* gene and *interferon‐γ* gene into the recombinant baculovirus genome at the polyhedron site. The *chIFN‐α* and *chIFN‐γ* genes were codon optimized according to amino acid sequences (GenBank IDs: ADU60333.1 and ABI83735.1) and synthesized. These two genes were individually inserted into the pVL1393 transfer vector, in which there are baculovirus recombination sequences on both sides of the MCS. The **pP10‐Cγ** vector was used to transfer the *chIFN‐γ* gene into the recombinant baculovirus genome at the *p10* gene site. The *chIFN‐γ* gene was inserted into the pP10 vector via *Bam*H I/*Not* I digestion.

2.2. Construction of the recombinant baculovirus {#mbo3979-sec-0004}
------------------------------------------------

The reBmBac vector was modified from BmNPV. An *E. coli* CopyControl origin of replication was inserted into the genome at chi‐cat gene site. And tetracycline resistance gene was inserted at polyhedrin gene site. These two make sure the baculovirus DNA can be edited and amplified in *E. coli*. The essential *ORF1629* gene was also partial deleted to make sure the highly recombination efficiency.

According to a published protocol (Datsenko & Wanner, [2000](#mbo3979-bib-0005){ref-type="ref"}; Liu et al., [2016](#mbo3979-bib-0019){ref-type="ref"}), the *p10* gene of reBmBac baculovirus genomic DNA was replaced by the *rpsL‐neo* cassette by phage λ‐Red recombinase in *E. coli*. Then, the *rpsL‐neo* cassette was replaced by the *chIFN‐γ* gene. The recombinant baculovirus shuttle vector containing the *chIFN‐γ* gene at the *p10* gene site was named **reBmBac‐p10Cγ**.

According to published procedures (Liu et al., [2016](#mbo3979-bib-0019){ref-type="ref"}), the pVL1393‐Cα or pVL1393‐Cγ vector was mixed with the reBmBac vector. The mixture was used to cotransfect Bm5 cells. *chIFN‐α* and *chIFN‐γ* genes were inserted into the baculovirus genome at the polyhedron gene site. The recombinant baculoviruses were named **reBm‐Cα** and **reBm‐Cγ**. A mixture of the pVL1393‐Cα vector and reBmBac‐p10Cγ was then utilized to cotransfect Bm5 cells. *chIFN‐α* was transferred into the reBmBac‐p10Cγ genome at the *polyhedron* gene site. The recombinant baculovirus, which contained the *chIFN‐α* gene at the *polyhedron* site and the *chIFN‐γ* gene at the *p10* site, was named **reBm‐Cαγ**. The recombinant baculoviruses reBm‐Cαγ, reBm‐Cα, and reBm‐Cγ were purified by plaque screening (Pen, Welling, & Welling‐Wester, [1989](#mbo3979-bib-0027){ref-type="ref"}).

2.3. Expression of interferon in silkworm larvae and pupae {#mbo3979-sec-0005}
----------------------------------------------------------

Fifth instar silkworm larvae or pupae were injected with 5 μl of cell culture media containing recombinant *Bm*NPV (10^7^--10^8^ plaque‐forming units (PFU) mL^−1^) between abdominal knobs on the backside. Silkworm larvae and pupae were reared at 25 \~ 27°C and 65% humidity for 108--120 hr. Larval hemolymph was collected by cutting prolegs, and 1‐phenyl‐2‐thiourea was added at 0.1 mM to prevent melanization. Larval hemolymph and pupae were stored at −20°C for subsequent assays.

2.4. Antiviral activity assay of recombinant interferon in chicken embryo fibroblasts {#mbo3979-sec-0006}
-------------------------------------------------------------------------------------

According to published procedures (Rein & Rubin, [1968](#mbo3979-bib-0030){ref-type="ref"}), chicken embryo fibroblasts (CEFs) were prepared. A CEF cell suspension was isolated from 9‐ to 11‐day‐old chicken embryos. The cell concentration was approximately 1 × 10^6^ cells per milliliter. CEF cells were seeded in 96‐well plates at a constant cell density of 1 × 10^5^ cells per well for 8--12 hr at 37°C in 5% CO~2~ in air.

A GFP‐reduction assay with VSV‐GFP was used to assay the antiviral activity of recombinant chicken IFNs in CEFs. Larval hemolymph containing IFN expression product was treated by ultrasonication. After centrifugation, the supernatant of the IFN product was filtered with a 0.22 μm syringe filter. Interferon supernatant was gradient diluted in DMEM with 7% FBS. After incubation with diluted IFN for 18--24 hr at 37°C in 5% CO~2~ in air, CEF cells were infected with VSV‐GFP at 10 TCID~50~ per well. After 24 hr, cell cytopathic effect (CPE) and green fluorescence were detected. The antiviral activity of IFNs was calculated according to the CPE reduction method (Ge et al., [2006](#mbo3979-bib-0009){ref-type="ref"}).

2.5. Inactivation of chicken interferon γ {#mbo3979-sec-0007}
-----------------------------------------

IFN‐α is both acid and heat resistant. However, IFN‐γ is easily deactivated by both acid (pH 2.0) and temperature (56°C) (Ho, Armstrong, & Breinig, [1975](#mbo3979-bib-0011){ref-type="ref"}). Thus, the antiviral activity of IFN‐α in the coexpression product was studied. The pH value of larval hemolymph or pupa product was adjusted to 2.0 ± 0.2 using a hydrochloric acid solution (0.1 M). After 24 hr of static incubation at 4°C and filtration, the pH value was adjusted to 7.0 ± 0.1 using a sodium hydroxide solution (1 M). After 1 hr of static incubation at 4°C and filtration, the sample was heat treated (56°C) for 30 min. After filtration with a 0.22 μm syringe filter, IFN‐γ of the product was deactivated.

The expression of IFN was detected by western blotting according to the Protein Blotting Guide (Bio‐Rad). Relative expression levels of IFN‐α and IFN‐γ in these products were detected by indirect ELISA.

3. RESULTS {#mbo3979-sec-0008}
==========

3.1. Generation of the recombinant baculoviruses reBm‐Cαγ, reBm‐Cα and reBm‐Cγ {#mbo3979-sec-0009}
------------------------------------------------------------------------------

Two transfer plasmids, pVL1393‐Cα and pVL1393‐Cγ, were used to transfer the *chIFN‐α* and *chIFN‐γ* genes into reBmBac for single expression of IFN. The recombinant baculoviruses reBm‐Cα and reBm‐Cγ, constructed though cotransfection of transfer plasmids and reBmBac genome DNA (Figure [1](#mbo3979-fig-0001){ref-type="fig"}a), were capable of expressing chIFN‐α and chIFN‐γ, respectively. In the IFN coexpression recombinant baculovirus reBm‐Cαγ, the *chIFN‐γ* gene was inserted into the reBmBac genome downstream of the *p10* promoter sequence through homologous recombination in *E. coli*. The *chIFN‐α* gene was inserted into the same reBmBac genome downstream of the *polyhedron* promoter sequence through cotransfection in cells (Figure [1](#mbo3979-fig-0001){ref-type="fig"}b).

![Schematic representation for the generation of recombinant viruses containing chicken IFNs. (a) Construction of recombinant baculoviruses containing a single interferon gene. During cotransfection of reBmBac DNA and foreign gene transfer vector, the interferon gene was inserted into baculovirus genome at the polyhedrin site. The *tetracycline* resistance (tet^R^) gene was replaced. (b) construction of a coexpression recombinant baculovirus containing *chIFN‐α* and *chIFN‐γ* at distinct gene sites. In *Escherichia coli*, *chIFN‐γ* was firstly inserted into reBmBac at *p10* gene site by using phage λ‐Red recombinase. Then, the reBmBac‐p10Cγ vector was purified and cotransfected with *chIFN‐α* transfer vector to prepare the coexpression recombinant baculovirus in *Bm* cells](MBO3-9-e979-g001){#mbo3979-fig-0001}

3.2. Expression and antiviral activity analyses of coexpression IFNs and single‐expression IFNs {#mbo3979-sec-0010}
-----------------------------------------------------------------------------------------------

The expression products of chIFN‐α and chIFN‐γ were analyzed by Western blotting (Figure [2](#mbo3979-fig-0002){ref-type="fig"}). Figure [2](#mbo3979-fig-0002){ref-type="fig"} demonstrates that an approximately 22 kDa protein band that reacted with an anti‐chIFN‐α antibody was detected in reBm‐Cαγ and reBm‐Cα expression samples. Likewise, an approximately 19 kDa protein band that reacted with an anti‐chIFN‐γ antibody was observed in reBm‐Cαγ and reBm‐Cγ expression samples. No corresponding immunoreactive protein was detected in the negative control sample from larval hemolymph infected with control *Bm*NPV.

![Western blot assay of chIFN‐α and chIFN‐γ expression in single‐ and coexpression products. The reBm‐Cαγ sample is larval hemolymph infected with the coexpression recombinant baculovirus reBm‐Cαγ. The reBm‐Cα and reBm‐Cγ samples are larval haemolymphs infected with the single‐expression recombinant baculovirus reBm‐Cα or reBm‐Cγ. chIFN‐α proteins were detected in reBm‐Cαγ and reBm‐Cα samples at approximately 22 kDa. ChIFN‐γ proteins were detected in reBm‐Cαγ and reBm‐Cγ samples at approximately 19 kDa. No corresponding immunoreactive protein was detected in control samples](MBO3-9-e979-g002){#mbo3979-fig-0002}

Antiviral activity of recombinant IFNs was assayed utilizing a CPE inhibition assay with CEF cells. Recombinant IFN products could inhibit VSV‐GFP infection in CEFs (Figure [3](#mbo3979-fig-0003){ref-type="fig"}). The antiviral activity assay results indicated that the antiviral potential of reBm‐Cα, reBm‐Cγ, and reBm‐Cαγ products were 3.26 ± 0.61 × 10^6^ IU/mL, 5.08 ± 0.43 × 10^6^ IU/mL, and 3.27 ± 0.50 × 10^7^ IU/mL in hemolymph, respectively. These recombinant baculovirus expression products were then acid (pH 2.0) and heat treated (56°C). IFN‐α is acid and heat resistant, but IFN‐γ is acid and heat labile (Ho et al., [1975](#mbo3979-bib-0011){ref-type="ref"}). Therefore, the antiviral activity of the reBm‐Cα product remained almost the same before and after treatment. The antiviral activity of the reBm‐Cγ product declined to an undetectable level. The antiviral activity of the reBm‐Cαγ product was still 5.78 ± 0.88 × 10^6^ IU/mL, which was due to IFN‐α activity. This activity was 2 times greater than that of the reBm‐Cα product. This enhanced expression level of IFN‐α must be due to *p10* gene deletion in coexpression recombinant baculovirus (Hitchman et al., [2010](#mbo3979-bib-0010){ref-type="ref"}).

![Antiviral activity assay of single‐expression IFNs versus coexpression IFNs. The antiviral activity of the reBm‐Cαγ product was approximately 5--10 times greater than that of the reBm‐Cα or reBm‐Cγ product. After acid and heat treatment (pH 2.0, 56°C), the antiviral activity of the reBm‐Cα product was almost the same as that before the treatments. The antiviral activity of the treated reBm‐Cγ product was negligible. The antiviral activity of the treated reBm‐Cαγ product was greater than that of chIFN‐α. It was approximately 1.7 times greater than that of the reBm‐Cα product](MBO3-9-e979-g003){#mbo3979-fig-0003}

The ELISA results for chIFN‐γ illustrate that the expression level of chIFN‐γ in reBm‐Cαγ‐infected larval hemolymph was approximately 2.5 times greater than that in reBm‐Cγ‐infected larval hemolymph (Figure [A1](#mbo3979-app-0001){ref-type="app"}).

3.3. The synergistic antiviral effect of interferon type I and II {#mbo3979-sec-0011}
-----------------------------------------------------------------

The reBm‐Cα and reBm‐Cγ products were diluted to 10 × 10^4^ IU/mL and mixed in different proportions. The antiviral activity of the mixtures was detected. The results revealed that chIFN‐α and chIFN‐γ (at a ratio of 1:2) enhanced the maximum antiviral activity, that is 17.92 ± 1.07 × 10^4^ IU/mL (Table [1](#mbo3979-tbl-0001){ref-type="table"}). This result indicated that an increased ratio of IFN type II caused an obvious synergistic antiviral effect of IFN type I and II.

###### 

Antiviral activity of a mixture of two types of interferon

  Ratio of the two types interferon   Theoretical value (×10^4^ IU/ml)   Measured value (×10^4^ IU/ml)   
  ----------------------------------- ---------------------------------- ------------------------------- --------------
  4                                   1                                  10                              10.04 ± 0.75
  2                                   1                                  10                              10.22 ± 0.59
  1                                   1                                  10                              11.41 ± 0.78
  1                                   2                                  10                              17.92 ± 1.07
  1                                   4                                  10                              14.05 ± 0.99

John Wiley & Sons, Ltd

3.4. Inhibitory effect of coexpression interferons on in vitro replication of Marek\'s disease virus {#mbo3979-sec-0012}
----------------------------------------------------------------------------------------------------

The highly oncogenic strain RB1B of Marek\'s disease virus (MDV) has the ability to replicate and develop plaques in CEFs. Chicken embryo fibroblasts treated with co‐ or single‐expression chIFNs were employed to determine the inhibitory effect on the in vitro replication of MDV. Mean PFU is listed in Table [2](#mbo3979-tbl-0002){ref-type="table"}. The results revealed that 800 IU of coexpression product completely inhibited MDV replication in CEFs. The same titer of single‐expression IFN products containing one of the two types of IFN could only partially inhibit MDV replication. This result indicated that chicken IFNs expressed in our baculovirus‐silkworm system have excellent anti‐MDV activity. This study further validated the synergistic antiviral potential of type I and type II IFNs.

###### 

Inhibitory effect of interferons on MDV

  Larval hemolymph sample     CK           reBm‐Cα      reBm‐Cγ      reBm‐Cαγ
  --------------------------- ------------ ------------ ------------ ----------
  Interferon dose (IU/well)   0            800          800          800
  Plaque (PFU/well)           18.5 ± 1.8   11.8 ± 0.9   10.3 ± 1.4   0
  16.0 ± 2.5                  9.8 ± 1.8    9.5 ± 1.5    0            
  20.0 ± 4.0                  12.5 ± 1.5   12.8 ± 1.7   0            

John Wiley & Sons, Ltd

4. DISCUSSION {#mbo3979-sec-0013}
=============

In our previous studies, the reBmBac recombinant baculovirus construction strategy was successfully established, and recombinant porcine IFN‐α was efficiently expressed (Liu et al., [2016](#mbo3979-bib-0019){ref-type="ref"}). Then, IFNs from several other species were successively expressed utilizing this system. All of the IFN products exhibited prominent antiviral activity.

In the present study, the coexpression of type I and II IFNs at different gene sites was successfully achieved using a single recombinant baculovirus. The type I IFN *chIFN‐α* gene was introduced at the *polyhedron* gene site. The *chIFN‐γ* gene, a type II IFN‐encoding gene, was inserted at the *p10* gene site. The antiviral potential of the coexpression product was five to ten times higher than that of any single‐expression product. After heat and acid treatment, the remaining IFN‐α antiviral activity of the coexpression product was approximately two times greater than that of the chIFN‐α single‐expression product. This finding indicates that the expression level of IFN‐α in the reBm‐Cαγ product was significantly higher than that in the reBm‐Cα product. ELISA results further augmented that multi‐IFN expression in the coexpression product was higher than that in the single‐expression product. This result was consistent with the antiviral assay. The increase in expression level is due to deletion of the *p10* gene. Just like *polyhedrin* gene, *p10* is a nonessential gene for baculovirus replication and budded virus production. And also, it is nonessential for recombinant protein expression, but with high expression level (Hitchman et al., [2010](#mbo3979-bib-0010){ref-type="ref"}). In recombinant baculovirus, polyhedrin promoter is the preference for foreign gene expression. The *polyhedrin* gene is replaced by a foreign gene. The saved cost of *polyhedrin* expression provides for the recombinant protein expression. In reBm‐Cαγ, the deletion of *p10* gene can also save a certain degree of cost of gene expression, even though the *p10* promoter is weaker than the *polyhedrin* promoter. And these saving costs could be used for foreign gene expression. Thus, in reBm‐Cαγ, the deletion of p10 gene enhances the chIFN‐α expression which driven by *polyhedrin* promoter, indirectly. This finding also provides an optimal direction for enhanced expression levels. However, the antiviral assay against VSV and MDV showed that the antiviral potential of the coexpression product was more than two times greater than that of any single‐expression product. This difference must be due to the synergistic effect of the two types of IFN. Type I and II IFNs display diverse antiviral mechanisms. Here, coadministration of these two IFNs exhibited synergistic effects and elevated antiviral potential. Hence, the coexpression of the two IFNs by employing the BES is significant and beneficial. The coexpression products displayed greater antiviral activity and synergistic effects than the single‐expression products. This strategy of combined administration of chicken IFNs can suppress viral diseases in the poultry industry.

The insertion of the *chIFN‐γ* gene at the *p10* gene site was mediated by the counterselection cassette *rpsL‐neo* and phage λ‐Red recombinase. There was no fundamental sequence or antibiotic resistance gene residue in the target gene site of the baculoviral genome. By employing this method, multiple gene insertion into various gene sites in one recombinant baculovirus can be achieved easily. This multigene baculovirus expression system can be a potential tool in many research fields. The BES is advantageous for antibody expression (Verma, Boleti, & George, [1998](#mbo3979-bib-0038){ref-type="ref"}). Previously, heavy‐ and light‐chain genes were inserted in the same gene site (Furuta et al., [2010](#mbo3979-bib-0007){ref-type="ref"}). Using the multigene expression strategy in the present study, heavy‐ and light‐chain genes can be introduced into different sites in one recombinant baculovirus, and enhanced expression levels will be achieved. rAAV packaging is another application area of the BES. In preceding studies, rAAV packaging required two or three recombinant baculoviruses, which individually contained cap, rep, and target genes (Aslanidi, Lamb, & Zolotukhin, [2009](#mbo3979-bib-0002){ref-type="ref"}; Negrete et al., [2007](#mbo3979-bib-0025){ref-type="ref"}). By employing our multigene expression strategy, rep, cap, and target genes can be inserted separately into the same recombinant baculovirus at the *egt*, *p10,* and *polyhedron* gene sites, respectively. The packaging efficiency of rAAV would thus be greater than that when using two or three recombinant baculoviruses (Galibert & Merten, [2011](#mbo3979-bib-0008){ref-type="ref"}).
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 {#mbo3979-sec-0020}

![ELISA assay of chIFN‐γ expression in reBm‐Cαγ and reBm‐Cγ product. The reBm‐Cαγ sample is larval haemolymph infected with coexpression recombinant baculovirus reBm‐Cαγ. reBm‐Cγ sample is larval haemolymph infected with the single‐expression recombinant baculovirus reBm‐Cγ. The mean absorbance (450 nm) of reBm‐Cαγ sample was around 2.5 times as much as that of reBm‐Cγ sample](MBO3-9-e979-g004){#mbo3979-fig-0004}
